GBT 500 Pill - yellow oval, 18mm
Generic Name: voxelotor
Pill with imprint GBT 500 is Yellow, Oval and has been identified as Oxbryta 500 mg. It is supplied by Global Blood Therapeutics Inc.
Oxbryta is used in the treatment of Sickle Cell Disease and belongs to the drug class miscellaneous uncategorized agents. Oxbryta 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GBT 500
Oxbryta
- Generic Name
- voxelotor
- Imprint
- GBT 500
- Strength
- 500 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous uncategorized agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Global Blood Therapeutics Inc.
- National Drug Code (NDC)
- 72786-0101 (Discontinued)
See also:
Casgevy
Casgevy (exagamglogene autotemcel) is a gene therapy that is given as a one-time intravenous ...
Lyfgenia
Lyfgenia (lovotibeglogene autotemcel) is a gene therapy that uses a viral vector and is given as a ...
Tepezza
Tepezza (teprotumumab) infusion is used for thyroid eye disease (TED). Includes Tepezza side ...
Accutane
Accutane (isotretinoin) is a form of vitamin A and is used to treat severe nodular acne. Includes ...
Adakveo
Adakveo (crizanlizumab-tmca) is used for the prevention of vasoocclusive crises (VOCs) in patients ...
Ammonul
Ammonul is used to treat a condition caused by too much ammonia in the blood. Includes Ammonul side ...
Amnesteem
Amnesteem is used for acne, acute nonlymphocytic leukemia, granuloma annulare, rosacea
Amondys 45
Amondys 45 (casimersen) is used to treat Duchenne muscular dystrophy (DMD) with a genetic mutation ...
More about Oxbryta (voxelotor)
- Check interactions
- Compare alternatives
- Reviews (7)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.